Lack of acceptance of guidelines for prevention of disseminated Mycobacterium avium complex infection in infants and children infected with human immunodeficiency virus

Pediatric Infectious Disease Journal

Volumn 17, Issue 12, 1998, Pages 1131-1135

  Chong, Chia Yin ^a   Husson, Robert N ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LYMPHOCYTE COUNT; MENTAL COMPLIANCE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ATTITUDE OF HEALTH PERSONNEL; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FEMALE; HUMANS; INFANT; MALE; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PRACTICE GUIDELINES; PRIMARY PREVENTION; UNITED STATES;

EID: 0032411355     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199812000-00006     Document Type: Article

References (13)

1. Benson CA. Diseases of the Mycobacterium avium complex in AIDS: epidemiology and clinical syndromes. Clin Infect Dis 1994; 18(Suppl 3):S218-22.
2. Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Spectrum of Disease project. Pediatr 1996;97:710-16.
3. Pierce M, Crampton S, Henry D, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996; 335:384-91.
4. Havlir DV, Dube MP, Sattler FR, et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin or both. N Engl J Med 1996;335: 392-8.
5. Nightingale SD, Cameron DW, Zarowny DP, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33.
6. Lewis LL, Butler KM, Husson RN, et al. Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium intracellulare infection. J Pediatr 1992;121:677-83.
7. Rutstein RM, Cobb P, McGowan KL, Pinto-Martin J, Starr SE. Mycobacterium avium intracellulare complex infection in HIV-infected children. AIDS 1993;7:507-12.
8. Hoyt L, Oleske J, Holland B, Connor E. Nontuberculous mycobacteria in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1992;11:354-60.
9. Horsburgh CR, Caldwell MB, Simonds RJ. Epidemiology of disseminated nontuberculous mycobacterial disease in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1993;12:219-22.
10. Gleason-Morgan D, Church JA, Ross LA. A comparative study of transfusion-acquired human immunodeficiency virus-infected children with and without disseminated Mycobacterium avium complex. Pediatr Infect Dis J 1994;3:484-8.
11. 1997 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 1997;46(RR-12):1-46.
12. 1997 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. Clin Infect Dis 1997;25(Suppl 3):S313-35.
13. Gross, PA. Practice guidelines for infectious diseases: rationale for a work in progress. J Infect Dis 1998;26:1037-41.